Syntis Bio is based in Boston. It has raised $87M in total funding. Latest round: Series A.
Syntis Bio funding overview
Syntis Bio is based in Boston. Syntis Bio has raised $87M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2025. The round record for Syntis Bio runs through 2025; nothing later has been disclosed. Investors on record include Apollo Labs, Bold Capital Partners, Cerity Partners Ventures, Colorcon Ventures, National Institutes of Health, Portal Innovations and 4 others. 10 distinct backers are named across the disclosed rounds.
Syntis Bio at a glance
Total raised
$87M
Latest round
Series A
Latest round date
July 2025
Headquarters
Boston
Notable investors
Apollo Labs, Bold Capital Partners, Cerity Partners Ventures, Colorcon Ventures, National Institutes of Health, Portal Innovations, Safar Partners, Woori Venture Partners
Frequently asked about Syntis Bio funding
How much has Syntis Bio raised?
Syntis Bio has raised $87M in total disclosed funding across the rounds on record.
Who has invested in Syntis Bio?
Apollo Labs, Bold Capital Partners, Cerity Partners Ventures, Colorcon Ventures, National Institutes of Health, Portal Innovations are named among the investors backing Syntis Bio.
What was the latest Syntis Bio funding round?
The most recent disclosed round is a Series A, announced in July 2025.
Where is Syntis Bio based?
Syntis Bio is based in Boston.
When did Syntis Bio last raise?
The last disclosed Syntis Bio round closed in July 2025 at Series A.
Totals shown for Syntis Bio aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.
